By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – Speaking at the JP Morgan Healthcare Conference here today, Life Technologies Chairman and CEO Greg Lucier provided further comments on the firm's launch of the Ion Proton Sequencer, a new instrument designed to sequence an entire human genome in a day for $1,000.

The new benchtop sequencer is priced at $149,000 and is the next generation of its Ion Personal Genome Machine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.